-
Innovation Ranking
Innovation Ranking - Novartis AG
Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz. Novartis conducts research in various disease areas through The Novartis Institutes for BioMedical Research (NIBR). The company...
-
Innovation Ranking
Innovation Ranking - Harrow Health Inc
Harrow Health Inc (Harrow Health) formerly known as Imprimis Pharmaceuticals Inc, owns a portfolio of healthcare businesses which also includes ImprimisRx, the ophthalmology pharmaceutical compounding business in the US and holds large equity positions in Eton Pharmaceuticals, Melt Pharmaceuticals and Surface Pharmaceuticals. The company is focused on developing innovative medications to serve ophthalmology industry in the marketplace. The company through its subsidiaries develops injectable Dropless Therapy formulations and topical LessDrops formulations. MAY-44 for treating dyspareunia and MAY-88 for treating interstitial...
-
Innovation Ranking
Innovation Ranking - Mersana Therapeutics Inc
Mersana Therapeutics Inc (Mersana) is a pharmaceutical company. It develops antibody-drug conjugates (ADC) for the treatment of cancer. The company’s pipeline product XMT-1660, XMT-2056, XMT-2068, and XMT-2175 an ADC which targets sodium-dependent phosphate transport protein NaPi2b utilizing Dolaflexin platform. Mersana utilizes various technologies including DolaLock Technology, Dolaflexin, Dolasynthen, and Immunosynthen in developing ADCs. Its products also include ASN004 which is in dose escalation stage. The company develops immunoconjugates to deliver payloads of anti-tumor agents directly to cancerous cells. Its products...
-
Innovation Ranking
Innovation Ranking - Adamis Pharmaceuticals Corp
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company. The company's pipeline products includes SYMJEPI (epinephrine), ZIMHI(naloxone) and APC-400 (tempol). Its SYMJEPI Injection is used for the emergency treatment of allergic reactions such as caused by the stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, idiopathic and exercise-induced anaphylaxis. Adamis develops products in the form of injections, gels and capsules for the treatment of allergy, opioid overdose, respiratory and inflammatory...
-
Innovation Ranking
Innovation Ranking - Anheuser-Busch InBev NV/SA
Anheuser-Busch InBev NV/SA (AB InBev) is a producer, distributor, and marketer of beer, alcoholic beverages, and soft drinks. The company’s product portfolio consists of both alcoholic and non-alcoholic beverages that include beer, rum, malt beverages and soft drinks. AB InBev markets and sells these products under various international and local brands, including Budweiser, Aguila, Stella Artois, Beck’s, Leffe, Hoegaarden, Skol, Bud Light, Victoria, Harbin, Corona, Brahma, and Quilmes. The company also holds exclusive rights to bottle, sell and distribute certain...
-
Innovation Ranking
Innovation Ranking - Lonza Group Ltd
Lonza Group Ltd (Lonza) is a contract manufacturing and development solutions company. It offers services including commercial mammalian and microbial manufacturing, clinical development, and manufacturing. It also offers high-potential active pharmaceutical ingredients, cell and gene therapy capabilities, advanced intermediates, oral drug product development services, cell-culture modeling, genome editing, endotoxin products, and research media and testing products. Lonza provides solutions for health and well-being, microbial and hygiene control, and composites and material protection. Lonza serves biotechnology, pharmaceutical, academic, and government research...
-
Innovation Ranking
Innovation Ranking - Exelixis Inc
Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment of cancer. The company’s marketed products include, Cometriq (cabozantinib), an inhibitor of multiple receptor tyrosine kinases; Cabometyx (cabozantinib) developed for the treatment of patients with advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). The company’s pipeline product candidates include zanzalintinib, XB002 and XL102 for the treatment of advanced or metastatic solid tumors and CBX-12 for advanced metastatic refractory...
-
Innovation Ranking
Innovation Ranking - Kellogg Co
Kellogg Co (Kellogg) is a producer and marketer of ready-to-eat cereal and convenience foods. Its product portfolio includes cereals, cookies, crackers, savory snacks, frozen waffles, toaster pastries, cereal bars, fruit-flavored snacks, and veggie foods. The company markets its snacks products under Kellogg’s Cheez-It, Murray, Pringles, Austin, Parati, and RXBAR, Bear Naked, Zoo Cartoon, Trink, Townhouse, Rice Bubble, and Kashi, Morningstar Farms and Eggo brand names. Kellogg supplies its products to retailers and supermarkets for resale through direct sales force, distributors,...
-
Innovation Ranking
Innovation Ranking - Marinus Pharmaceuticals Inc
Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company. It discovers, develops and commercializes medicines for the treatment of rare genetic epilepsies and other seizure disorders. The company’s product is Ganaxolone, a novel gamma-aminobutyric acid (GABA) receptor modulator, which is developed in intravenous (IV) and oral formulations. Marinus Pharmaceuticals carries out research and development, educational grants, and other services. It markets products under the brand name Ztalmy. The company product help in the treatment of acute and chronic care settings,...
-
Innovation Ranking
Innovation Ranking - MorphoSys AG
MorphoSys AG (Morphosys) is commercial-stage biopharmaceutical company that develop monoclonal antibodies for therapeutic and research applications, with focused on the treatment of cancer and autoimmune diseases. The company's product pipeline includes tafasitamab, pelabresib, cpi-0209, gantenerumab, otilimab, ianalumab, abelacimab, felzartamab, setrusumab, NOV-8, NOV-14 and MOR210. Its Tafasitamab is a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody directed against CD19 in clinical development for the treatment of B cell malignancies. The company provides clinical trials for cancer and inflammatory disorders. Morphosys also...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.